Sub-classification of intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinomas

doi:10.3748/wjg.v21.i37.10604

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 37

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8849)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.

Item

Count

PDF

659

WORD

206

HTML

4286

Tables (1-2)

492

Sum=5643

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1514

Download

1692

Sum=3206

Oct 7, 2015 (publication date) through Oct 30, 2025

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Topic Highlight

World J Gastroenterol. Oct 7, 2015; 21(37): 10604-10608
Published online Oct 7, 2015. doi: 10.3748/wjg.v21.i37.10604

Table 1 Substaging of intermediate-stage; Bolondi substaging system

Intermediatesubstage	B1	B2	B3	B4
Child-Pugh score	5-7	5-6	7	8-9
Up-to-7 criterion	In	Out	Out	Any
1^st option	TACE	TACE or TARE		BSC
Alternative	LT	Sorafenib	Research trial	LT
	TACE + Ablation		TACE
	TACE + Ablation		Sorafenib
Median survival time (mo)	41.0	22.1	14.1	17.2

Modification from Reference[9,11]. TACE: Transarterial chemoembolization; TARE: Transarterial radioembolization; LT: Liver transplantation; BSC: Best supportive care.

Full Size Table

Table 2 Substaging of intermediate-stage; proposal from japanese society of transcatheter hepatic arterial embolization

Intermediate-substage	B1	B2	B3
Child-Pugh score	5-6	5-8	9
4-of-7 cm criterion	In	In (CP 7-8)	Any
		or
		Out (CP 5-8)
2-yr survival rate	77.2%	59.5%	16.7%
Median survival time (mo)	40.5	28.1	13.0

CP: Child-Pugh.

Full Size Table

Citation: Yamakado K, Hirota S. Sub-classification of intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinomas. World J Gastroenterol 2015; 21(37): 10604-10608
URL: https://www.wjgnet.com/1007-9327/full/v21/i37/10604.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i37.10604